Researchers Identify Neural Circuit Linking Spinal Cord and Brain in Chronic Pain
A study published in Nature details a neural circuit connecting the spinal cord, brain, and back to the spinal cord that contributes to chronic pain. The research used mouse models to map this pathway and test its role in pain persistence. Findings suggest potential targets for pain management therapies.
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Researchers have identified a specific neural circuit that links the spinal cord to the brain and back to the spinal cord, playing a role in the maintenance of chronic pain. The study, published in the journal Nature, focused on mouse models to deconstruct this pathway. The circuit involves projections from the spinal cord to the brain and returning signals that amplify pain signals over time.
The investigation mapped the spino-brain-spinal cord circuit using advanced imaging and genetic techniques. Sensory neurons in the spinal cord transmit initial pain signals to brain regions, including the parabrachial nucleus and insular cortex. From there, descending projections reinforce the pain response, leading to prolonged sensitivity.
dissect the circuit, the team employed optogenetics to activate or inhibit specific neurons.
Activation of the descending pathway in mice induced behaviors associated with ongoing pain, such as guarding and reduced activity. Inhibiting the circuit reduced pain hypersensitivity in models of inflammatory and neuropathic pain. The research highlighted the role of certain neuron types, including those expressing calcitonin gene-related peptide in the spinal cord.
These findings build on prior knowledge of ascending pain pathways but emphasize the bidirectional nature of the circuit in chronic conditions. The study was conducted by a team led by researchers at institutions including the University of Zurich and the Scripps Research Institute.
pain affects millions worldwide, often persisting after the initial injury heals.
This circuit's identification provides a anatomical basis for why pain becomes self-sustaining. Future research may explore pharmacological or neuromodulation approaches targeting this pathway. The study notes limitations, including its focus on rodent models, which may not fully translate to humans.
Clinical trials would be needed to validate these mechanisms in people. The paper, titled 'Deconstruction of a spino-brain–spinal cord circuit that drives chronic pain,' was published on October 18, 2023. No direct quotes from the authors were highlighted in the source summary, but the work underscores the need for circuit-specific interventions in pain management.
Affected populations include those with conditions like arthritis, nerve damage, or post-surgical pain, where current treatments often fall short.
Key Facts
Story Timeline
2 events- October 18, 2023
Nature publishes study on spino-brain-spinal cord circuit in chronic pain.
1 source@Nature - Prior to publication
Researchers map and test neural circuit using mouse models and optogenetics.
1 source@Nature
Potential Impact
- 01
Identification of circuit may improve understanding of pain persistence mechanisms.
- 02
Study may guide development of targeted drugs for chronic pain circuits.
- 03
Findings could inform neuromodulation therapies for pain management.
- 04
Research highlights need for human validation of rodent pain models.
Transparency Panel
Related Stories
deccanchronicle.comHantavirus Cases Reported on MV Hondius Cruise Ship, Three Fatalities Amid Low Transmission Risk
A hantavirus outbreak on the MV Hondius cruise ship has killed three passengers and sickened seven others, prompting an international response coordinated by the World Health Organization. The ship, carrying 147 people from 23 nationalities, is set to sail to Spain's Canary Islan…
techjuice.pkImperial College London Study Analyzes Changes in Wildfire Weather Patterns in Northern Ireland
A new report from Imperial College London highlights growing wildfire threats in Northern Ireland due to more favorable conditions, especially in spring. Researchers note increased drought and fire-prone weather, exacerbated by climate change. The findings point to longer fire se…
FDA Commissioner Defends Drug Rejection Decisions
The FDA commissioner defended recent drug rejections in a CNBC interview, citing adherence to scientific reviews amid reports of agency turmoil. Criticism includes a high-profile denial of a melanoma treatment from Replimune and pressure from President Trump over vape approvals.…